Pharming Group N.V. Purchase Of Interests In Investments Accounted For Using Equity Method
Pharming Group N.V. (PHAR) reported Purchase Of Interests In Investments Accounted For Using Equity Method of $739.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Notes
ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod · last filed 2026-04-02
EUR
| Period end | Purchase Of Interests In Investments Accounted For Using Equity Method 12 month |
|---|---|
| 2020-12-31 | 288.00K EUR 20-F · filed 2021-04-07 |
| 2019-12-31 | 2.50M EUR 20-F · filed 2021-04-07 |
| 2018-12-31 | 0.00 EUR 20-F · filed 2021-04-07 |
USD
| Period end | Purchase Of Interests In Investments Accounted For Using Equity Method 12 month |
|---|---|
| 2025-12-31 | $739.00K 20-F · filed 2026-04-02 |
| 2024-12-31 | $0.00 20-F · filed 2026-04-02 |
| 2023-12-31 | $0.00 20-F · filed 2026-04-02 |
| 2021-12-31 | $0.00 20-F · filed 2022-04-06 |
| 2020-12-31 | $329.00K 20-F · filed 2022-04-06 |
| 2019-12-31 | $2.81M 20-F · filed 2022-04-06 |